# South Korea Neurology Devices Market > South Korea Neurology Devices Market Research Report: Size, Share, Trend Analysis By Product Type (neurostimulation, interventional neurology, csf management, neurosurgery devices) and By End Users (hospitals & clinics, specialty center) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.85% - **2024:** $ 555 Million - **2025:** $ 593.02 Million - **2035:** $ 1,150 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Abbott (US), NeuroPace (US), Stryker (US), Natus Medical (US), LivaNova (GB), ElectroCore (US), Cerenovus (US) **Report ID:** MRFR/HC/49560-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-neurology-devices-market-51317 --- ## Market Summary ## **South Korea Neurology Devices Market Overview** **As per MRFR analysis, the South Korea Neurology Devices Market Size was estimated at 363.8 (USD Million) in 2023.****The South Korea Neurology Devices Market Industry is expected to grow from 392.25(USD Million) in 2024 to 897.87 (USD Million) by 2035. The South Korea Neurology Devices Market CAGR (growth rate) is expected to be around 7.819% during the forecast period (2025 - 2035).** ### **Key South Korea Neurology Devices Market Trends Highlighted** The South Korea Neurology Devices Market is observing important changes due to new technologies and increased focus on neurology health. Growth in the older population coupled with the growing prevalence of stroke, epilepsy, and other neurological disorders has increased the demand for innovative neurology devices. The government in South Korea is putting significant funds in health systems, developing programs that improve patient treatment and technology available to them. This has spurred local manufacturers to devote attention to the R&D and design of advanced devices for specific neurological conditions. In addition, the enablement of automation and machine learning changes the market with the appropriate AI diagnostic tools. These innovations improve the outcomes patients receive by providing early diagnosis and better planned individual treatment. Telemedicine also became popular after the COVID-19 pandemic, allowing patients, particularly in rural areas, to have better access to medical services. This is in line with the government’s efforts on shifting to digital healthcare. There are many opportunities in the South Korean market, especially in design and development of wearable neurological devices that monitor health conditions in real-time. A rise in the interest in home-based tracking solutions is observed since they offer patients greater control and ease in following their treatment plans. With the collaboration of tech companies and healthcare practitioners, prominent solutions to the changing face of neurological care are bound to emerge. Recently, the adoption of advanced neurosurgery has made treating patients with modern neurological devices more accessible. Thus, South Korea’s neurology devices market would greatly take advantage from new innovations and government investment, along with an appeal to patients and their wellbeing, as the healthcare sector integrates more philosophy of technology. ## **South Korea Neurology Devices Market Drivers** ### Rising Prevalence of Neurological Disorders The South Korea Neurology Devices Market Industry is significantly driven by the increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. According to the Korean Neuropsychiatric Association, neurological disorders account for approximately 7% of the national disease burden, with the number of dementia patients projected to reach 3 million by 2060. This alarming statistic emphasizes the urgent need for advanced neurology devices, enhancing the market's growth prospects.Additionally, the South Korean government is actively updating its healthcare policies to ensure better patient care in neurology, which increases the demand for cutting-edge devices in the market. ### Technological Advancements in Neurology Devices Technological innovations significantly contribute to the growth of the South Korea Neurology Devices Market Industry. With advancements in neuromodulation techniques, imaging technologies, and wearable devices, healthcare providers are employing more effective treatments for neurological conditions. The Ministry of Health and Welfare in South Korea has reported a 40% increase in funding for Research and Development (R&D) of advanced medical technologies over the past five years.This fiscal support encourages local companies to innovate and develop sophisticated neurology devices, thereby boosting market expansion. ### Government Initiatives and Healthcare Policies The South Korean government is heavily investing in healthcare infrastructure and policies aimed at improving neurological health services. In 2020, the government allocated approximately 200 billion South Korean won to enhance neurological care services and support device manufacturers. This commitment fosters a conducive environment for growth in the South Korea Neurology Devices Market Industry as it enables easier access to funding and resources for device development.The renewed focus on patient-centered care is pivotal for driving the demand for advanced neurology devices across hospitals and clinics nationwide. ### Growing Geriatric Population The demographic shift towards an aging population in South Korea has a profound impact on the South Korea Neurology Devices Market Industry. By 2030, it is estimated that over 20% of South Korea's population will be aged 65 and above, according to Statistics Korea. As this demographic is particularly vulnerable to neurological conditions, the demand for specialized neurology devices will significantly increase. Furthermore, the National Health Insurance Service has begun to expand coverage for neurological treatments for the elderly, further stimulating market growth as more patients gain access to necessary devices and therapies. ## **South Korea Neurology Devices Market Segment Insights** ### **Neurology Devices Market Product Type Insights** The South Korea Neurology Devices Market encompasses a diverse range of product types that are pivotal to advancing neurological care and treatment. Within this market, neurostimulation devices play an essential role by providing therapeutic solutions for various neurological disorders, including epilepsy and chronic pain management. These devices utilize electrical impulses to modulate nerve activity and have gained traction due to increasing acceptance and integration in clinical practice.  Interventional neurology is another critical segment, focusing on minimally invasive techniques for diagnosing and treating complex neurovascular disorders, such as aneurysms and strokes.This segment is particularly significant as it reduces recovery time and enhances patient outcomes, reflecting a shift towards less invasive treatment methodologies. The CSF management segment addresses crucial needs around the management of cerebrospinal fluid, vital for patients with conditions like hydrocephalus.  These devices facilitate proper drainage and pressure regulation, improving quality of life. Lastly, neurosurgery devices, which include tools and equipment used in surgical procedures concerning the nervous system, are indispensable in enabling complex surgical interventions.This segment is characterized by innovation and technological advancements, aiming to enhance precision and safety in surgical procedures.  The interplay among these various product types illustrates the dynamic nature of the South Korea Neurology Devices Market, which is bolstered by a supportive healthcare infrastructure, significant Research and Development initiatives, and an increasing prevalence of neurological conditions, creating numerous opportunities for growth and innovation in this critical field. ### **Neurology Devices Market End User Insights** The End User segment of the South Korea Neurology Devices Market is composed mainly of hospitals and clinics, along with specialty centers. Hospitals and clinics play a key role in the delivery of neurology services, as they provide essential healthcare infrastructure for diagnosis and treatment. These establishments are equipped with advanced technology and skilled neurologists, contributing significantly to the growth of the South Korea Neurology Devices Market revenue.  Specialty centers, focused on neurology and related fields, offer tailored services and treatments, making them important for comprehensive patient care.The demand in these areas is driven by the increasing prevalence of neurological disorders in South Korea, alongside a growing focus on enhancing healthcare services. Moreover, the collaboration between hospitals and specialty centers allows for a streamlined approach to patient treatment, fostering innovation in device utilization and encouraging enhanced patient outcomes.  As the healthcare sector in South Korea continues to evolve, these end users are expected to adapt, leveraging new neurology devices to meet the growing health demands. This segment underlines the dynamic nature of the South Korea Neurology Devices Market statistics, reflecting both technological advancements and changing patient needs. ## **South Korea Neurology Devices Market Key Players and Competitive Insights** The South Korea Neurology Devices Market presents a dynamic landscape characterized by rapid advancements in technology and increasing healthcare demands related to neurological conditions. As this market continues to evolve, key players are vying for market share by innovating and tailoring their products to meet the unique needs of the South Korean population.  The competitive environment is influenced not only by technological advancements but also by regulatory changes, collaborations, and partnerships among companies striving to enhance patient outcomes. Companies within this sector are focusing on diverse neurology devices, including diagnostic equipment, monitoring systems, and treatment devices, making it crucial for each player to maintain a strategic edge over competitors.Johnson & Johnson has established a significant presence in the South Korean Neurology Devices Market, reinforced by its reputation for quality and innovation.  The company leverages its extensive research and development capabilities to deliver a range of neurology products that cater specifically to the needs of healthcare professionals and patients in South Korea. With a commitment to integrating advanced technologies into its devices, Johnson & Johnson has successfully launched several neuromodulation solutions that are designed to address various neurological disorders.  The company’s strong distribution network and partnerships with local healthcare institutions enhance its market access and make its products highly accessible to both specialists and patients. Johnson & Johnson's ongoing investment in training and education for healthcare providers further solidifies its position as a leader in the region.NeuroSigma operates within the South Korea Neurology Devices Market with a focus on innovative devices aimed at treating neurological disorders such as epilepsy and attention deficit hyperactivity disorder (ADHD). The company is known for its development of neurostimulation technologies, including the Monarch eTNS System, which has been shown to be effective in reducing seizure frequency and improving patient quality of life.  With a strong emphasis on research and collaboration, NeuroSigma has positioned itself as a key player in the region, utilizing clinical research and patient feedback to enhance its product offerings. The company's strategy includes forming strategic alliances and exploring mergers and acquisitions to expand its footprint and improve its technological capabilities. Through these efforts, NeuroSigma aims to deepen its market penetration and enhance the therapeutic options available to healthcare providers in South Korea, thereby playing an instrumental role in the evolving landscape of neurology care in the country. ### **Key Companies in the South Korea Neurology Devices Market Include** ## **South Korea Neurology Devices Market Industry Developments** The South Korea Neurology Devices Market has witnessed significant developments recently. In August 2023, Medtronic announced the launch of its innovative deep brain stimulation system designed for neurological conditions, providing advanced treatment options for patients. Meanwhile, in September 2023, NeuroSigma secured regulatory approval for its non-invasive neuromodulation device, aimed at treating epilepsy, which indicates growth in non-surgical solutions in the market.  Abbott Laboratories is also advancing with its Research and Development initiatives, focusing on next-generation neurostimulation devices to enhance patient outcomes. Notably, Boston Scientific expanded its product offerings in July 2023 by acquiring a niche technology that aims to improve neurovascular intervention procedures.  Additionally, there has been a noticeable increase in market valuation for companies like Stryker and Penumbra, highlighting a growing demand for advanced neurovascular devices following rising incidences of neurological disorders, especially among the aging population in South Korea. The government of South Korea is investing heavily in healthcare technology, further fueling the market's expansion and innovation. Growth in this segment is expected to impact healthcare delivery positively, addressing urgent neurological healthcare needs in the region. ## **South Korea Neurology Devices Market Segmentation Insights** ### **Neurology Devices Market Product Type****Outlook** ### **Neurology Devices Market End User****Outlook** ## Market Drivers ### Growing Awareness and Education There is a growing awareness of neurological disorders and the importance of early diagnosis and treatment in South Korea. Educational campaigns and initiatives by healthcare organizations are informing the public about the symptoms and risks associated with neurological conditions. This heightened awareness is leading to an increase in patient consultations and, consequently, a higher demand for neurology devices. As more individuals seek medical advice, the neurology devices market is expected to benefit from this trend, with an anticipated growth rate of around 7% over the next few years. ### Increased Healthcare Expenditure The rising healthcare expenditure in South Korea is a significant driver for the neurology devices market. With the government and private sectors investing more in healthcare, the total healthcare spending is projected to reach around $200 billion by 2026. This increase in funding allows for the procurement of advanced neurology devices, which are essential for effective diagnosis and treatment of neurological conditions. Furthermore, as healthcare policies evolve to prioritize mental health and neurological disorders, the demand for specialized devices is likely to grow, thereby enhancing the market's potential. ### Regulatory Support and Framework The regulatory environment in South Korea is becoming increasingly supportive of the neurology devices market. The government has implemented policies aimed at expediting the approval process for new medical devices, which encourages innovation and market entry. This regulatory support is crucial for manufacturers looking to introduce cutting-edge neurology devices. With a streamlined approval process, companies can bring their products to market more quickly, thereby meeting the growing demand for advanced neurological care. As a result, the neurology devices market is likely to experience accelerated growth, driven by the influx of new technologies. ### Rising Incidence of Neurological Disorders The increasing prevalence of neurological disorders in South Korea is a primary driver for the neurology devices market. Conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy are becoming more common, with estimates suggesting that around 1.5 million individuals are affected by these disorders. This rising incidence necessitates the development and adoption of advanced neurology devices for diagnosis and treatment. The market is projected to grow at a CAGR of approximately 8.5% over the next five years, driven by the demand for innovative solutions that enhance patient outcomes. As healthcare providers seek to improve the quality of care, investments in neurology devices are likely to increase, further propelling market growth. ### Technological Innovations in Device Development Technological advancements play a crucial role in shaping the neurology devices market. Innovations such as brain-computer interfaces, advanced neuroimaging techniques, and minimally invasive surgical tools are transforming the landscape of neurological care. In South Korea, companies are investing heavily in research and development, with expenditures reaching approximately $500 million annually. These innovations not only improve the efficacy of treatments but also enhance patient comfort and recovery times. As the demand for more sophisticated and effective devices rises, the neurology devices market is expected to expand significantly, with new products entering the market regularly. ## Future Outlook The [Neurology Devices Market](https://www.marketresearchfuture.com/reports/neurology-devices-market-9768) is projected to grow at 6.85% CAGR from 2025 to 2035, driven by technological advancements, increasing neurological disorders, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven diagnostic tools for early detection of neurological conditions. - Expansion of telehealth services for remote monitoring of patients with neurological disorders. - Investment in portable neuromodulation devices for at-home treatment options. By 2035, the neurology devices market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product: Neurostimulation (Largest) vs. Interventional Neurology (Fastest-Growing) In the South Korea neurology devices market, Neurostimulation captures the largest share among the product segments, driven by its growing applications in treating chronic pain, epilepsy, and mood disorders. Interventional Neurology follows as a burgeoning segment, leveraging advanced techniques to address cerebral vascular incidents, gaining traction due to an increase in awareness and the effectiveness of minimally invasive procedures. The growth dynamics of these segments are particularly compelling. Neurostimulation continues to dominate due to technological advancements and rising investments in R&D. On the other hand, the Interventional Neurology segment is rapidly expanding, driven by an aging population and increasing incidences of neurovascular disorders. This has resulted in heightened demand for innovative solutions and therapies that cater to these pressing health issues. Neurostimulation (Dominant) vs. CSF Management (Emerging) Neurostimulation stands as the dominant force in the South Korea neurology devices market, characterized by its robust technology and wide acceptance among healthcare providers. It includes devices that use electrical impulses to modulate nerve activity, making it invaluable in neurological treatments. In contrast, the CSF Management segment, while emerging, is gaining significant attention due to the rising incidence of conditions like hydrocephalus and increased awareness of cerebrospinal fluid disorders. It focuses on creating solutions for effective management, including shunt technologies and drainage systems, making strides towards improving patient outcomes. As the market evolves, both segments are expected to complement one another in addressing neurological challenges. ### By End User: Hospitals & Clinics (Largest) vs. Specialty Center (Fastest-Growing) In the South Korea neurology devices market, the distribution of market share among end users indicates a significant dominance of hospitals and clinics. These facilities account for the largest share, driven by their extensive resources, advanced technology, and the high volume of neurology-related treatments offered. Specialty centers, while smaller in market share, are rapidly gaining traction due to specialized services and targeted therapeutic approaches, drawing in patients seeking advanced care that may not be available in general hospitals. The growth trends in this segment are particularly influenced by the increasing prevalence of neurological disorders, which has led to a higher demand for specialized treatments. Hospitals & clinics are expanding their neurology departments, while specialty centers are becoming a preferred choice for patients due to focused care and innovation in treatment techniques. The synergy between these two types of establishments fosters further growth as they complement each other in providing comprehensive neurological healthcare solutions. Hospitals & Clinics (Dominant) vs. Specialty Center (Emerging) Hospitals and clinics serve as the dominant players in the South Korea neurology devices market, equipped with the necessary infrastructure and skilled personnel to handle complex neurological conditions. Their ability to provide comprehensive diagnostic and treatment services not only attracts a larger patient base but also enables them to invest in the latest neurology devices, thereby enhancing patient outcomes. On the other hand, specialty centers are emerging as a vital segment due to their ability to offer tailored treatment options. These centers typically focus on specific neurological disorders and utilize advanced technologies, positioning themselves as leaders in innovation. The growing preference for personalized medicine and specialized care is driving the rise of specialty centers, making them a dynamic force within the market. ## Competitive Benchmarking The neurology devices market in South Korea is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of neurological disorders. Key players such as Medtronic (US), Boston Scientific (US), and Abbott (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Medtronic (US) emphasizes its commitment to developing cutting-edge neurostimulation devices, while Boston Scientific (US) is known for its robust portfolio of minimally invasive solutions. Abbott (US) is actively pursuing collaborations with local healthcare providers to tailor its offerings to the specific needs of the South Korean market, thereby enhancing its competitive positioning.The market structure appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to improve efficiency and reduce costs. This strategy not only enhances responsiveness to market demands but also aligns with the growing emphasis on sustainability within the industry. The collective influence of these key players shapes a competitive environment where innovation and operational excellence are paramount. In October Medtronic (US) announced the launch of its latest neurostimulation device, which integrates advanced AI algorithms to personalize treatment for patients with chronic pain. This strategic move is likely to enhance patient outcomes and solidify Medtronic's leadership in the neurology devices sector. The incorporation of AI into their product line reflects a broader trend towards digitalization in healthcare, positioning the company favorably against competitors. In September Boston Scientific (US) expanded its product offerings by acquiring a local startup specializing in neuroimaging technology. This acquisition not only diversifies Boston Scientific's portfolio but also enables the company to leverage innovative imaging solutions that could enhance surgical precision. Such strategic actions indicate a proactive approach to maintaining competitive advantage through technological integration. In August Abbott (US) entered into a partnership with a South Korean research institution to develop next-generation neurotherapeutics. This collaboration underscores Abbott's commitment to innovation and its strategy of aligning with local expertise to accelerate product development. By investing in research partnerships, Abbott is likely to enhance its competitive edge in the rapidly evolving neurology devices market. As of November the competitive trends in the neurology devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, allowing companies to pool resources and expertise to drive innovation. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and deliver high-quality, reliable products. ## Recent News & Developments The South Korea Neurology Devices Market has witnessed significant developments recently. In August 2023, Medtronic announced the launch of its innovative deep brain stimulation system designed for neurological conditions, providing advanced treatment options for patients. Meanwhile, in September 2023, NeuroSigma secured regulatory approval for its non-invasive neuromodulation device, aimed at treating epilepsy, which indicates growth in non-surgical solutions in the market.  Abbott Laboratories is also advancing with its Research and Development initiatives, focusing on next-generation neurostimulation devices to enhance patient outcomes. Notably, Boston Scientific expanded its product offerings in July 2023 by acquiring a niche technology that aims to improve neurovascular intervention procedures.  Additionally, there has been a noticeable increase in market valuation for companies like Stryker and Penumbra, highlighting a growing demand for advanced neurovascular devices following rising incidences of neurological disorders, especially among the aging population in South Korea. The government of South Korea is investing heavily in healthcare technology, further fueling the market's expansion and innovation. Growth in this segment is expected to impact healthcare delivery positively, addressing urgent neurological healthcare needs in the region. ## Report Scope | MARKET SIZE 2024 | 555.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 593.02(USD Million) | | MARKET SIZE 2035 | 1150.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.85% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott (US), NeuroPace (US), Stryker (US), Natus Medical (US), LivaNova (GB), ElectroCore (US), Cerenovus (US) | | Segments Covered | Product, End User | | Key Market Opportunities | Advancements in neurostimulation technologies enhance treatment options in the neurology devices market. | | Key Market Dynamics | Technological advancements drive innovation in neurology devices, enhancing treatment options and patient outcomes in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the overall market valuation of the neurology devices market in South Korea in 2024?** A: The overall market valuation was $555.0 Million in 2024. **Q: What is the projected market valuation for the neurology devices market in South Korea by 2035?** A: The projected market valuation for 2035 is $1150.0 Million. **Q: What is the expected CAGR for the South Korea neurology devices market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 6.85%. **Q: Which product segment had the highest valuation in the South Korea neurology devices market in 2024?** A: The Neurosurgery Devices segment had the highest valuation at $185.0 Million in 2024. **Q: What is the projected valuation range for the Neurostimulation segment by 2035?** A: The projected valuation range for the Neurostimulation segment is between $150.0 Million and $300.0 Million. **Q: Which end user segment contributed the most to the neurology devices market in South Korea in 2024?** A: The Hospitals & Clinics segment contributed the most, with a valuation of $300.0 Million in 2024. **Q: What is the projected valuation range for the Specialty Center end user segment by 2035?** A: The projected valuation range for the Specialty Center segment is between $255.0 Million and $500.0 Million. **Q: Who are the key players in the South Korea neurology devices market?** A: Key players include Medtronic, Boston Scientific, Abbott, NeuroPace, Stryker, Natus Medical, LivaNova, ElectroCore, and Cerenovus. **Q: What is the valuation range for the Interventional Neurology segment in 2024?** A: The valuation range for the Interventional Neurology segment in 2024 was between $120.0 Million and $250.0 Million. **Q: How does the projected growth of the neurology devices market in South Korea compare to its 2024 valuation?** A: The market is expected to grow from $555.0 Million in 2024 to $1150.0 Million by 2035, indicating substantial growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-neurology-devices-market-51317*